• 2021 11.19-11.21
  • B2F, Conference Hall, Administration Building, Shuinan Campus, China Medical University.
  • No.100, Sec.1, Jingmao Rd., Beitun Dist., Taichung City, Taiwan(R.O.C)

Brief & Idea

Cancer has become the top ten leading causes of death and seriously affects the health of human beings all over the world. It arises from the transformation from normal cells into cancerous one through complex mechanisms. Deciphering the molecular mechanisms of cancer causing or suppressing has become the foremost focus of biomedical research towards eradicating cancer, which is an important issue of global concern. In recent years, worldwide biomedical research, including in Taiwan has made unprecedented progress in both quality and quantity. Case in point is the recent speedy and effective development of several SARS-Cov2 vaccines and remedies in a short period of time. Modern biomedical research requires knowledge sharing and inter needs of many cross disciplines. Therefore, close interaction and collaboration among diverse fields are becoming a crucial practice in biomedical science. The inception of ICABS aims to promote scientific sharing between experts in Taiwan and internationally on a mutually beneficial basis.

PLENARY KEYNOTE SPEAKERS

The highlight of this conference is the participation of both international and domestic top scholars in the field of biomedical sciences. Invited international speakers include the following 9 members of the US Academy of Sciences Drs. William Kaelin (2019 Nobel Laureate) , Randy Schekman (2013 Nobel Laureate), Tony Hunter, Lewis Cantley, Irving Weissman, Zhijian James Chen, Dinshaw Patel, and Ron DePinho. Also invited are other renown international scholars, including Drs. Nagashiro Minato, Zhimin James Lu, Xiang-Dong Fu, Dihua Yu, and Wenyi Wei. Domestic experts include Academicians of Academia Sinica, Drs. Chien-Jen Chen (formal Vice President of Taiwan, R.O.C.), Pan -Chyr Yang ,Chi-Huey Wong, and Mien-Chie Hung .

The topic covers the most advanced and forward-looking biomedical topics , including: Signal Transduction and Cancer, Cancer Metabolism, Stem Cells, Cancer Immunology, Novel technology and translational innovation, and Innovative Cancer Therapy.

KEYNOTE SPEAKERS

William G. Kaelin Jr.
2019 Nobel Laureate
Member, National Academy of Sciences, USA
Professor, Department of Medicine
Dana-Farber Cancer Institute
Harvard Medical School, MA

Chien-Jen Chen
Past Vice President of Taiwan, ROC
Foreign Member, National Academy of Sciences, USA
Professor, Graduate Institute of Epidemiology
National Taiwan University College of Public Health,
Taiwan, ROC

Randy W. Schekman
2013 Nobel Laureate
Member, National Academy of Sciences, USA
Professor, Department of Molecular and Cell Biology
University of California, Berkeley, CA

PLENARY SPEAKERS

Session 1. Signal Transduction and Cancer

Tony Hunter
2018 Tang Prize for Biopharmaceutical Science
Member, National Academy of Sciences, USA
Professor, Department of Molecular and Cell Biology
Salk Institute, La Jolla, CA, USA

Mien-Chie Hung
President
China Medical University, Taichung, Taiwan
Academician, Academia Sinica, Taiwan, ROC
Past Vice President of Basic Research,
MD Anderson Cancer Center, Houston, TX, USA

Session 2: Cancer Metabolism

Lewis C. Cantley
Member, National Academy of Sciences, USA
Professor in Cancer Biology of Medicine
Meyer Director, Sandra and Edward Meyer Cancer Center
Joan & Sanford I. Weill Medical College of Cornell University, New York, NY USA

Zhimin (James) Lu
Kuangcheng Wang Distinguished Chair
Director, Cancer Center
Dean, Institute of Translational Medicine
Zhejiang University, Hangzhou, China

Session 3: Stem Cells

Irving L. Weissman
Member, National Academy of Sciences, USA
Professor of Pathology and Developmental Biology
Director, Ludwig Center for Cancer Stem Cell Research
Director, Institute of Stem Cell Biology and
Regenerative Medicine
Stanford University, Stanford, CA, USA

Xiang-Dong Fu
Professor, Department of Cellular and Molecular Medicine
University of California, San Diego, La Jolla, CA, USA

Session 4: Cancer Immunology

Zhijian (James) Chen
Member, National Academy of Sciences, USA
Investigator, Howard Hughes Medical Institute
George L. MacGregor Distinguished Chair
in Biomedical Science
Professor, Department of Molecular Biology
UT Southwestern Medical Center, Dallas, TX, USA

Nagahiro Minato
President
Kyoto University, Kyoto, Japan

Dihua Yu
Hubert L. & Olive Stringer Distinguished Chair
in Basic Science
Professor and Chair ad interim,
Department of Molecular and Cellular Oncology
The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA

Session 5: Novel technology and translational innovation

Dinshaw J. Patel
Member, National Academy of Sciences, USA
Abby Rockefeller Mauzé Chair,
Department of Experimental Therapeutics
Sloan Kettering Institute
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Chi-Huey Wong
Member, National Academy of Sciences, USA
Academician, Academia Sinica, Taiwan, ROC
Distinguished Research Fellow, Genomics Research Center
Genomics Research Center, Academia Sinica, Taiwan, ROC
Scripps Family Chair Professor, Department of Chemistry
The Scripps Research Institute, La Jolla, CA, USA

Session 6: Innovative Cancer Therapy

Ronald A. DePinho
Member, National Academy of Sciences, USA
Past President of MD Anderson Cancer Center
Professor, Department of Cancer Biology,
Division of Basic Science Research
The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Pan-Chyr Yang
Academician, Academia Sinica, Taiwan, ROC
Past President of National Taiwan University
Chair Professor, Department of Internal Medicine
National Taiwan University, Taiwan, ROC

Wenyi Wei
Professor, Department of Pathology
Director, Biochemistry Program
Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, MA, USA

Sponsors

科技部
中國醫藥大學
中國醫藥大學附設醫院

NEWS

Get any news about International Conference on Advanced Biomedical Sciences.

2021.11.16 |臺灣國際創新生物醫學峰會-交通車

 

臺灣國際創新生物醫學峰會-交通車

　

11月19日

11月20日

星期五

星期六

第一班車

第二班車

第一班車

第二班車

台中高鐵站-CMU水湳校總區

發車時間

07:45

人員1

08:00

人員2

07:45

人員1

08:00

人員2

候車時間

07:30

07:45

07:30

07:45

CMU水湳校總區-台中高鐵站

發車時間

17:50

人員1

17:50

人員2

17:20

人員1

17:20

人員2

候車時間

17:30

17:30

17:00

17:00

遊覽車臨停區

高鐵站1樓6號出口

關懷大樓1樓校門口

交通車需先至水湳校區接送隨車人員，再前往高鐵站

2021.11.04 | 校本部鄰近交通資訊

 

  • 校本部⇄高鐵台中站公車轉乘路線

    搭乘82、101路線公車：「高鐵烏日站」上車->於「大德國中站」下車 -> 步行約15分鐘抵達校本部。

  • 校本部⇄台鐵台中站公車轉乘路線

    搭乘525路線公車：「台中車站(台灣大道)」上車->於「經貿大鵬路口站」下車 -> 步行約5分鐘抵達校本部。
    搭乘6、9、61、11、82、101路線公車：「台中車站(台灣大道)」上車->於「大德國中站」下車 -> 步行約15分鐘抵達校本部。

 

2021.10.29 |Parking information:

 

 

Due to TCDC regulation, CMU parking lots will not be opened to general public.
For ICABS attendee, please refer to the following map if you plan to drive to conference venue.
The parking space shown on the map is free of charge.

2021.10.18 |Questions on registration confirmation and obtaining a pass to enter CMU campus

 

 

  • For those who have completed registration and have not received any confiramtion email on either abstract submission or payment please contact info@icabs.org.tw
  • To comply the regulations by TCDC and CMU, all visitors are asked to fill out the COVID-19 related questionnaires prior to entering CMU campus. For those visitors who do not have Taiwan ID card please fill out the paper version of the questionnaires at the entrance of CMU campus. The pass is valid for 7 days. Please fill it out after 11/15.
    http://vwebap02.cmu.edu.tw/utility_rpt/prg_Data/nCOV_Visitor_Questionnaire.aspx

2021.10.06 |

UPDATES on conference

The conference has been modified to a hybrid format.  Due to the travel restrictions imposed by the Taiwan government, all international speakers will not be able to visit Taiwan in person. Their talks will either be delivered via live videos or prerecorded ones in conference venue. All domestic speakers will still present in person. Meet-the-Expert luncheons are canceled. Abstract deadline has been extended to Oct 29, 2021.


2021.09.08 |

Call for Paper

We welcome submissions on areas related to (A) signal transduction and cancer, (B) cancer metabolism, (C) stem cells, (D) cancer immunology, (E) Novel technology and translational innovation, and (F) innovative cancer therapy. Submissions will be reviewed by the Scientific Committee.
＊Deadline for submission: Oct. 29, 2021
＊All submissions must be in English.
＊Submissions will be reviewed by the Scientific Committee.
＊Results will be released and sent to the applicant by email, no later than Nov. 8, 2021

2021.05.18 |

Meet-the-Expert Lunchen

There will be 17 meet-the-expert luchens for those who are interested in meeting international and domestic experts. Lunch will only be provided to registrants.

'